Application 207883

Type
ANDA
Sponsor
PRINSTON PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREGABALINPREGABALINCAPSULE;ORAL25MGNoNo
002PREGABALINPREGABALINCAPSULE;ORAL50MGNoNo
003PREGABALINPREGABALINCAPSULE;ORAL75MGNoNo
004PREGABALINPREGABALINCAPSULE;ORAL100MGNoNo
005PREGABALINPREGABALINCAPSULE;ORAL150MGNoNo
006PREGABALINPREGABALINCAPSULE;ORAL200MGNoNo
007PREGABALINPREGABALINCAPSULE;ORAL225MGNoNo
008PREGABALINPREGABALINCAPSULE;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
43547-506PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-507PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-508PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-509PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-510PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-511PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-512PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent
43547-513PREGABALINpregabalinSolco Healthcare US, LLCANDACurrent